Residual complexes containing SMARCA2 (BRM) underlie the oncogenic drive of SMARCA4 (BRG1) mutation.

Wilson BG, Helming KC, Wang X, Kim Y, Vazquez F, Jagani Z, Hahn WC, Roberts CW.

Molecular and Cell Biology

January 13, 2014

https://pubmed.ncbi.nlm.nih.gov/24421395/